Dr. Reddy's Laboratories
RDY
#1704
Rank
HK$92.06 B
Marketcap
HK$110.08
Share price
0.07%
Change (1 day)
0.22%
Change (1 year)

Dr. Reddy's Laboratories (RDY) - Total debt

Total debt on the balance sheet as of September 2025 : HK$5.12 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's total debt is HK$5.12 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Dr. Reddy's Laboratories - Total debt on balance sheet (from 2001 to 2025)

Total debt by year

Year Total debt Change
2025-03-31HK$4.25 B126.51%
2024-03-31HK$1.87 B45.99%
2023-03-31HK$1.28 B-63.14%
2022-03-31HK$3.49 B8.51%
2021-03-31HK$3.21 B41.52%
2020-03-31HK$2.27 B-47.58%
2019-03-31HK$4.33 B-29.02%
2018-03-31HK$6.11 B3.74%
2017-03-31HK$5.89 B50.2%
2016-03-31HK$3.92 B-26.88%
2015-03-31HK$5.36 B-7.24%
2014-03-31HK$5.78 B10.03%
2013-03-31HK$5.25 B6.89%
2012-03-31HK$4.91 B19.25%
2011-03-31HK$4.12 B60.67%
2010-03-31HK$2.56 B-15.02%
2009-03-31HK$3.02 B-19.61%
2008-03-31HK$3.75 B-16.32%
2007-03-31HK$4.49 B-16.85%
2006-03-31HK$5.40 B965.57%
2005-03-31HK$0.50 B458.62%
2004-03-31HK$90.72 M67.59%
2003-03-31HK$54.13 M122%
2002-03-31HK$24.38 M-96.3%
2001-03-31HK$0.65 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
HK$473.68 B 9,134.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$132.90 B 2,491.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
HK$185.75 B 3,521.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
HK$249.28 B 4,759.76%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
HK$198.75 B 3,774.71%๐Ÿ‡ซ๐Ÿ‡ท France